Sex ratio | 1 |
Age years, median | 33 (17–87) |
Comorbidities | |
Age >65 years old | 6 |
Hypertension | 4 |
Cardiovascular disease | 2 |
Diabetes | 1 |
Chronic obstructive pulmonary disease | 4 |
Chronic kidney disease | 2 |
AA amyloidosis | 3 |
Treatment regimen | |
Colchicine | 26/27 |
Colchicine 1 mg/day | 15 |
Colchicine 1.5 mg/day | 5 |
Colchicine 2 mg/day | 5 |
Colchicine 2.5 mg/day | 1 |
Interleukin 1 inhibitor | 4 |
TNF alpha inhibitor | 1 |
Signs and symptoms | |
Fever | 17 |
Cough | 11 |
Asthenia | 11 |
Shortness of breath | 12 |
Myalgia | 9 |
Anosmia | 10 |
Dysgeusia | 7 |
Headache | 8 |
Diarrhoea | 2 |
Interstitial pneumonia in CT scan | 6 |
Nasal RT-PCR | 14 |
Serology | 12 |
Admission to hospital | 7 |
Oxygen therapy | 6/7 |
Nasal cannula | 4/7 |
Invasive mechanical ventilation | 3/7 |
Prognosis | |
Admission to intensive care unit | 3 |
Discharged | 4 |
Died | 2 |
Outcome | |
Total recovery | 19 |
Recovery with persistent asthenia | 5 |
Recovery with persistent dyspnoea | 1 |
TNF, tumour necrosis factor.